Physician profile
Jayson A Morgan
NPI 1932425345
$1,383.54
in general payments reported to CMS, 2019-2025
13 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $357 · 2023: $156 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $684.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $391.76 | 2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $189.04 | 2021 | |
| Novartis Pharmaceuticals Corporation | $153.83 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $142.87 | 2022-2023 | Lifevest |
| Abiomed | $136.58 | 2025 | |
| Alnylam Pharmaceuticals INC. | $119.69 | 2021 | |
| W. L. Gore & Associates, INC. | $63.95 | 2022 | |
| Boston Scientific Corporation | $42.56 | 2023 | Watchman Access System, Rhythmia Mapping System |
| Alexion Pharmaceuticals, INC. | $33.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $32.84 | 2022-2023 | Xarelto |
| Fujifilm Healthcare Americas Corporation | $32.26 | 2022 | |
| Orthofix Medical, INC. | $29.31 | 2023 | Spinal-Stim, Spinal-Stim |
| Merck Sharp & Dohme LLC | $15.18 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayson Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.